Analysts Estimate RadNet (RDNT) to Report a Decline in Earnings: What to Look Out for

Company Overview - RadNet (RDNT) is expected to report a year-over-year decline in earnings of 25% with earnings per share (EPS) projected at $0.15 for the quarter ended December 2024, while revenues are anticipated to increase by 9$458.06 million [3][12] - The earnings report is scheduled for release on February 28, 2025, and the actual results will significantly influence the stock price depending on whether they meet or exceed expectations [2][3] Earnings Estimates and Revisions - The consensus EPS estimate has been revised down by 40% over the last 30 days, indicating a bearish sentiment among analysts regarding RadNet's earnings prospects [4][10] - The Most Accurate Estimate for RadNet is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -5.43%, which complicates the prediction of an earnings beat [10][11] Earnings Surprise History - RadNet has a history of beating consensus EPS estimates, having surpassed expectations in three out of the last four quarters, including a +20% surprise in the last reported quarter [12][13] - Despite this history, the current combination of a negative Earnings ESP and a Zacks Rank of 3 suggests uncertainty regarding the likelihood of an earnings beat in the upcoming report [11][16] Industry Context - Another player in the medical diagnostics sector, LifeStance Health Group (LFST), is expected to report a loss of $0.04 per share for the same quarter, reflecting a year-over-year increase of 66.7$312.87 million, up 11.5% [17][18] - LifeStance Health has maintained its EPS estimate over the last 30 days but has a negative Earnings ESP of -25.00%, combined with a Zacks Rank of 2 (Buy), indicating a challenging outlook for beating consensus estimates [18]